Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic ReviewJennifer L. Caswell‐Jin, Allison W. Kurian, Sylvia K. Plevritis et al.|JNCI Cancer Spectrum|2018Cited by 328
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012Sylvia K. Plevritis, Jeanne S. Mandelblatt, Aimee M. Near et al.|JAMA|2018Cited by 301
Analysis of Breast Cancer Mortality in the US—1975 to 2019Jennifer L. Caswell‐Jin, Sylvia K. Plevritis, Liyang Sun et al.|JAMA|2024Cited by 268
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance ImagingSylvia K. Plevritis, Alan M. Garber, Allison W. Kurian et al.|JAMA|2006Cited by 260
Survival Analysis of Cancer Risk Reduction Strategies for <i>BRCA1/2</i> Mutation CarriersAllison W. Kurian, Sylvia K. Plevritis, Bronislava M. Sigal|Journal of Clinical Oncology|2009Cited by 240